Dthera Sciences (DTHR) Attends 31st Annual ROTH Conference
Dthera Sciences (OTCQB: DTHR) is working to improve the lives of seniors and individuals suffering from neurodegenerative diseases, as well as those who care for them. Dthera is developing DTHR-ALZ, a medical device that has been granted Breakthrough Device designation by the FDA for the mitigation of the symptoms of agitation and depression associated with Alzheimer's disease. To the company's knowledge, DTHR-ALZ is the first product to receive Breakthrough Device designation for the treatment of Alzheimer's disease, and Dthera Sciences is only the second digital therapeutic company to receive this designation. For more information, visit the company's website at www.dthera.com.…







